タンパク質発現市場 – 2029年までの世界予測

Report Overview

The global Protein Expression market is projected to reach USD 4.82 billion in 2029 and is from USD 3.41 billion by 2024, at a CAGR of 7.1% during the forecast period. Factors such as the increasing demand for biologics supported by the rise in R&D activities in the pharmaceutical and biopharmaceutical industry and the growing use of artificial intelligence and machine learning to enhance protein-based studies are supporting the growth of the market.

世界のタンパク質発現市場は、2029年に48億2,000万米ドルに達し、2024年までに34億1,000万米ドルに達すると予測されており、予測期間中のCAGRは7.1%です。

Moreover, factors such as the ongoing shift toward the development of personalized medicines, the rise in outsourcing services for clinical activities, the growing emphasis on the use of plant-based and cell-free expression systems, and the development of synthetic protein production technologies provide growth opportunities for players within the protein expression market. However, the high cost of protein expression reagents and instruments and the challenges associated with various expression systems are expected to restrain the growth of this market.

“The product segment registered the highest growth rate in the protein expression market, by offerings, during the forecast period”

In 2023, the products segment registered the highest growth rate within the protein expression market by offerings. Factors such as the rise in protein-based research and increasing approvals and commercialization of biologics, such as antibodies and vaccines are supporting the high growth of this segment. The products segment includes various reagents & kits, expression vectors, competent cells, and instruments that aid during various phases of protein expression. Reagents & kits accounted for the largest segment of the protein expression products market due to the continuous demand for these products during the protein expression workflow. Advancements in protein expression technologies and the launch of new and efficient reagents and kits are also supporting the growth of this product segment. Additionally, the rising focus on personalized medicine and biologics, such as antibodies and vaccines, is creating more demand for these products.

“The academic research  institutes registered the highest growth rate in the protein expression services market, by end user, during the forecast period”

The academic research institute end user segment registered the highest growth rate within the protein expression services market by end user during the forecast period. Factors such as the increasing demand for innovative research solutions for biological and biomedical research supported by an increase in funding and grants from governments and pharmaceutical companies are supporting the high growth of this end user segment. Moreover, there is an increase in the number of collaborations between research institutes and pharmaceutical companies for the development of protein-based therapies such as antibodies and vaccines for the treatment of various chronic illnesses. This high growth is projected to continue during the forecast period.

“North America: The largest and fastest-growing region in the Protein Expression market”

The protein expression market in North America is projected to register the highest growth rate during the forecast period. This high growth is attributed to the presence of an established biotechnology and pharmaceuticals sector focusing on the development of protein-based therapies leading to a high demand for protein expression products and services. The region has key protein expression products and services suppliers and end-users as well as advanced research facilities and large R&D expenditures. In addition, the rise of chronic conditions such as cancer and diabetes has also supported the need for new protein-based drugs, increasing the demand for efficient protein expression technologies. In addition, the support and funding from the government for life sciences research also support the large market share of North America in the global protein expression market.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 32%, Tier 2 – 44%, and Tier 3 – 24%
• By Designation: (Managers) – 45%, (CXOs, Directors)- 30%, and(Executives) – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -5%, Middle East- 5%, Africa-5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• GenScript (US)
• Agilent Technologies, Inc. (US)
• Takara Bio Inc. (Japan)
• Lonza (Switzerland)
• Promega Corporation (US)
• OriGene Technologies, Inc. (US)
• Qiagen (Netherlands)
• Bio-Rad Laboratories, Inc. (US)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Bioneer Corporation (South Korea)
• LGC Limited (UK)
• Sino Biological, Inc. (China)
• New England BioLabs (US)
• LifeSensors Inc. (US)
• Jena Bioscience GmbH (Germany)
• Charles River Laboratories (US)
• Corning Incorporated (US)
• Eurofins Scientific (Luxembourg)
• Ajinomoto Co., Inc. (Ajinomoto Bio-Pharma Services) (Japan)
• Syngene International Limited (India)
• Aragen Life Sciences Ltd. (India)

Research Coverage:

This report provides a detailed picture of the global Protein Expression Market. It aims at estimating the size and future growth potential of the market across different segments such as the system type, offerings, workflow, application, products end user, services end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the protein expression market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the protein expression market. Competitive analysis of upcoming startups in the protein expression market ecosystem is covered in this report.

Reasons to buy this report :

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall protein expression market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing demand for biologics, Rise in R&D in pharmaceutical and biopharmaceutical industries, Growing use of artificial intelligence and machine learning, Increasing shift toward personalized medicines, and Growing outsourcing of clinical activities), restraints (High cost of protein expression offerings and the dominance of small molecules in drug development), opportunities (Growing emphasis on plant-based and cell-free expression systems, Booming markets in emerging economies, Increasing development of new synthetic protein production technologies, and Growing use of recombinant proteins), and challenges (Production cost and efficiency issues) influencing the growth of the protein expression market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the protein expression market
• Market Development: Comprehensive information about lucrative markets – the report analyses the protein expression market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the protein expression market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), GenScript (US), Takara Bio Inc. (Japan), Lonza (Switzerland), among others in protein expression market.

Table of Contents

1               INTRODUCTION              44

1.1           STUDY OBJECTIVES       44

1.2           MARKET DEFINITION   44

1.3           STUDY SCOPE   45

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      45

1.3.2        INCLUSIONS AND EXCLUSIONS 46

1.3.3        YEARS CONSIDERED      47

1.4           CURRENCY CONSIDERED            47

1.5           STAKEHOLDERS               47

1.6           SUMMARY OF CHANGES               48

2               RESEARCH METHODOLOGY       49

2.1           RESEARCH DATA              49

2.1.1        SECONDARY DATA          50

2.1.2        PRIMARY DATA 50

2.2           MARKET ESTIMATION METHODOLOGY               52

2.2.1        MARKET ESTIMATION  52

2.2.2        INSIGHTS FROM PRIMARY EXPERTS        54

2.2.3        TOP-DOWN APPROACH                55

2.3           MARKET GROWTH RATE PROJECTIONS                56

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 58

2.5           RESEARCH ASSUMPTIONS           59

2.6           RESEARCH LIMITATIONS             59

2.7           RISK ANALYSIS  60

3               EXECUTIVE SUMMARY  61

4               PREMIUM INSIGHTS       66

4.1           PROTEIN EXPRESSION MARKET OVERVIEW        66

4.2           NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING AND COUNTRY, 2023                67

4.3           PROTEIN EXPRESSION MARKET SHARE, BY SYSTEM TYPE, 2024 VS. 2029          67

4.4           PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2023           68

4.5          PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2023        68

4.6           PROTEIN EXPRESSION MARKET, BY COUNTRY  69

5               MARKET OVERVIEW       70

5.1           INTRODUCTION              70

5.2           MARKET DYNAMICS       70

5.2.1        DRIVERS               71

5.2.1.1    Increasing demand for biologics        71

5.2.1.2    Rise in R&D in pharmaceutical and biopharmaceutical industries                 74

5.2.1.3    Growing use of artificial intelligence and machine learning                 74

5.2.1.4    Increasing shift toward personalized medicines               75

5.2.1.5    Growing outsourcing of clinical activities         76

5.2.2        RESTRAINTS      77

5.2.2.1    High cost of protein expression offerings         77

5.2.2.2    Renewed focus on small molecules in drug development                 77

5.2.3        OPPORTUNITIES              78

5.2.3.1    Growing emphasis on plant-based and cell-free expression systems  78

5.2.3.2    Booming market in emerging economies          78

5.2.3.3    Increasing development of synthetic protein production technologies           79

5.2.3.4    Growing use of recombinant proteins               80

5.2.4        CHALLENGES    80

5.2.4.1    Production cost and efficiency issues                80

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            81

5.4           PRICING ANALYSIS          82

5.4.1        AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS               82

5.4.2        AVERAGE SELLING PRICE, BY KEY PLAYER           83

5.4.2.1    Average selling price of system types, by key player       83

5.4.2.2    Average selling price trend of protein expression instruments,

by key player          85

5.4.3        AVERAGE SELLING PRICE, BY REGION   86

5.4.3.1    Average selling price of protein expression consumable products,

by region                 86

5.4.3.2    Average selling price trend of protein expression instruments,

by region                 88

5.5           SUPPLY CHAIN ANALYSIS             89

5.6           VALUE CHAIN ANALYSIS               90

5.7           ECOSYSTEM ANALYSIS  93

5.8           INVESTMENT/FUNDING ACTIVITY          95

5.9           TECHNOLOGY ANALYSIS             96

5.9.1        KEY TECHNOLOGIES     96

5.9.1.1    Recombinant DNA technology           96

5.9.1.2    Transfection technologies   96

5.9.1.2.1 Reagent-based transfection                 96

5.9.1.2.2 Instrument-based transfection           97

5.9.1.2.3 Virus-based transfection     98

5.9.1.3    Protein expression systems 98

5.9.1.3.1 Bacterial expression systems               99

5.9.1.3.2 Mammalian expression systems         99

5.9.1.3.3 Yeast expression systems    99

5.9.1.3.4 Insect expression systems   99

5.9.1.3.5 Cell-free expression systems               99

5.9.2        ADJACENT TECHNOLOGIES       100

5.9.2.1    Extraction technologies       100

5.9.2.1.1 Non-mechanical methods   100

5.9.2.1.2 Mechanical methods            101

5.9.2.2    Purification and characterization technologies                101

5.9.2.2.1 Protein purification technologies       101

5.9.2.2.2 Protein characterization technologies               101

5.9.3        COMPLEMENTARY TECHNOLOGIES       102

5.9.3.1    High-throughput technologies           102

5.9.3.2    Computation protein designing         102

5.10         PATENT ANALYSIS          103

5.11         TRADE ANALYSIS             106

5.11.1      IMPORT DATA  106

5.11.2      EXPORT DATA  108

5.12         KEY CONFERENCES AND EVENTS, 2024–2025        109

5.13         REGULATORY ANALYSIS               110

5.13.1      REGULATORY LANDSCAPE         110

5.13.1.1  North America      110

5.13.1.2  Europe   110

5.13.1.3  Emerging economies            111

5.13.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             111

5.14         PORTER’S FIVE FORCES ANALYSIS           115

5.14.1      INTENSITY OF COMPETITIVE RIVALRY 116

5.14.2      BARGAINING POWER OF SUPPLIERS       116

5.14.3      BARGAINING POWER OF BUYERS             116

5.14.4      THREAT OF NEW ENTRANTS      116

5.14.5      THREAT OF SUBSTITUTES          117

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     117

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           117

5.15.2      BUYING CRITERIA           118

5.15.2.1  Buying criteria for protein expression products               118

5.15.2.2  Buying criteria for protein expression services                120

5.16         IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET               121

5.16.1      INTRODUCTION              121

5.16.2      MARKET POTENTIAL FOR PROTEIN EXPRESSION APPLICATIONS 121

5.16.3      AI USE CASES     122

5.16.4      KEY COMPANIES IMPLEMENTING AI      123

5.16.5      FUTURE OF GENERATIVE AI IN PROTEIN EXPRESSION ECOSYSTEM       123

6               PROTEIN EXPRESSION MARKET, BY OFFERING 124

6.1           INTRODUCTION              125

6.2           PRODUCTS         125

6.2.1        REAGENTS & KITS            128

6.2.1.1    Increasing use for cloning, transfection, purification, and characterization to spur growth          128

6.2.2        EXPRESSION VECTORS  131

6.2.2.1    Growing production of complex proteins to propel market                 131

6.2.3        COMPETENT CELLS        133

6.2.3.1    Increasing demand for therapeutic proteins to expedite growth                 133

6.2.4        INSTRUMENTS & SOFTWARE     136

6.2.4.1    Increasing demand for biopharmaceuticals and personalized therapies to augment growth              136

6.3           SERVICES             138

6.3.1        GROWING UTILIZATION OF PROTEIN EXPRESSION SERVICES FOR LARGE-SCALE PRODUCTION TO FUEL MARKET                 138

7               PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE                 141

7.1           INTRODUCTION              142

7.2           MAMMALIAN CELL EXPRESSION SYSTEMS           142

7.2.1        CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS                 146

7.2.1.1    High viability, rapid growth, and improved expression levels to support growth      146

7.2.2        HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS                 148

7.2.2.1    Wide usage in transient transfection studies to augment growth                 148

7.2.3        OTHER MAMMALIAN CELL SYSTEMS      151

7.3           PROKARYOTIC EXPRESSION SYSTEMS   154

7.3.1        ESCHERICHIA COLI SYSTEMS     157

7.3.1.1    High cell density and low cost of media to stimulate growth                 157

7.3.2        OTHER PROKARYOTIC EXPRESSION SYSTEMS   159

7.4           INSECT CELL EXPRESSION SYSTEMS       162

7.4.1        BACULOVIRUS SYSTEMS               165

7.4.1.1    Increasing production of biologically active and functional recombinant proteins to speed up growth        165

7.4.2        OTHER INSECT CELL EXPRESSION SYSTEMS       167

7.5           YEAST EXPRESSION SYSTEMS    170

7.5.1        PICHIA SYSTEMS              173

7.5.1.1    Rising production of antibody fragments, and vaccines to fuel growth    173

7.5.2        SACCHAROMYCES SYSTEMS       175

7.5.2.1    Increasing use of saccharomyces systems for producing heterologous proteins to accelerate growth      175

7.5.3        OTHER YEAST EXPRESSION SYSTEMS    178

7.6           CELL-FREE EXPRESSION SYSTEMS           180

7.6.1        INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET  180

7.7           ALGAL-BASED EXPRESSION SYSTEMS    183

7.7.1        GROWING USE OF ALGAL-BASED EXPRESSION SYSTEMS IN ANTIBODY AND VACCINE GENERATION TO BOOST MARKET                 183

8               PROTEIN EXPRESSION MARKET, BY WORKFLOW                 186

8.1           INTRODUCTION              187

8.2           CLONING & TRANSFECTION      187

8.2.1        CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT MARKET 187

8.3           TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM)              190

8.3.1        GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET   190

8.4           EXTRACTION, PURIFICATION, AND CHARACTERIZATION     192

8.4.1        NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET   192

9               PROTEIN EXPRESSION MARKET, BY APPLICATION                 195

9.1           INTRODUCTION              196

9.2           THERAPEUTIC APPLICATIONS  196

9.2.1        RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH   196

9.3           RESEARCH APPLICATIONS          199

9.3.1        GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET 199

9.4           INDUSTRIAL APPLICATIONS      202

9.4.1        INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH                 202

10            PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER     206

10.1         INTRODUCTION              207

10.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 207

10.2.1      INCREASING APPROVALS FOR BIOLOGICS TO STIMULATE GROWTH   207

10.3         ACADEMIC & RESEARCH INSTITUTES    210

10.3.1      RISE IN GOVERNMENT AND PRIVATE FUNDING TO CONTRIBUTE TO MARKET GROWTH      210

10.4         CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS)             213

10.4.1      INCREASING OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING AND CLINICAL TRIALS TO SUSTAIN MARKET    213

10.5         OTHER END USERS         217

11            PROTEIN EXPRESSION SERVICES MARKET, BY END USER                 220

11.1         INTRODUCTION              221

11.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 221

11.2.1      INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH     221

11.3         ACADEMIC & RESEARCH INSTITUTES    224

11.3.1      RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH                 224

11.4         OTHER END USERS         227

12            PROTEIN EXPRESSION MARKET, BY REGION       230

12.1         INTRODUCTION              231

12.2         NORTH AMERICA             231

12.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 237

12.2.2      US           237

12.2.2.1  Growing focus on developing new therapeutics and protein-based drugs to drive market                237

12.2.3      CANADA               242

12.2.3.1  Increasing incidence of cancer and prevalence of public-private partnerships to sustain growth           242

12.3         EUROPE               246

12.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      251

12.3.2      GERMANY           252

12.3.2.1  Increasing proteomics-based research and healthcare investments to promote growth          252

12.3.3      UK          256

12.3.3.1  Growing development of immunotherapies, vaccines, and proteomics to fuel market   256

12.3.4      FRANCE                260

12.3.4.1  Rise in funding for proteomics and genomics to spur growth                 260

12.3.5      ITALY    265

12.3.5.1  Growing life science research supported by universities and research institutions to boost market                 265

12.3.6      SPAIN    269

12.3.6.1  Increasing international collaborations for drug development to fuel market             269

12.3.7      NETHERLANDS 273

12.3.7.1  Presence of advanced infrastructure to fuel market        273

12.3.8      REST OF EUROPE             277

12.4         ASIA PACIFIC     281

12.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 287

12.4.2      CHINA  288

12.4.2.1  Extensive government funding in genomics and protein research to boost market     288

12.4.3      JAPAN   292

12.4.3.1  Increasing initiatives by government associations in life sciences sector to support market growth        292

12.4.4      INDIA    297

12.4.4.1  Rising collaborations between private sector and academia to facilitate growth    297

12.4.5      AUSTRALIA         301

12.4.5.1  Growing focus on developing new proteins and peptides to drive market    301

12.4.6      SOUTH KOREA  305

12.4.6.1  Increasing research & development of novel therapies to facilitate growth    305

12.4.7      REST OF ASIA PACIFIC   310

12.5         LATIN AMERICA                314

12.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 319

12.5.2      BRAZIL 320

12.5.2.1  Growing industrial investments to propel market           320

12.5.3      MEXICO                324

12.5.3.1  Increase in chronic diseases and robust research ecosystem to expedite growth    324

12.5.4      ARGENTINA       328

12.5.4.1  Rise in biotechnology and pharmaceutical research & development to augment growth       328

12.5.5      REST OF LATIN AMERICA             332

12.6         MIDDLE EAST   336

12.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST                 341

12.6.2      GCC COUNTRIES              342

12.6.2.1  Strategic investments between government authorities and private players to drive market           342

12.6.3      REST OF MIDDLE EAST 346

12.7         AFRICA 350

12.7.1      FAVORABLE INSURANCE PROGRAMS AND CLINICAL TRIALS TO CONTRIBUTE TO MARKET GROWTH               350

12.7.2      MACROECONOMIC OUTLOOK FOR AFRICA        354

13            COMPETITIVE LANDSCAPE         356

13.1         OVERVIEW          356

13.2         KEY PLAYER STRATEGY/RIGHT TO WIN, 2021–2024                 356

13.3         REVENUE ANALYSIS, 2021–2023  359

13.4         MARKET SHARE ANALYSIS, 2023                 360

13.5         COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023        363

13.5.1      STARS   363

13.5.2      EMERGING LEADERS     363

13.5.3      PERVASIVE PLAYERS      363

13.5.4      PARTICIPANTS 364

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         365

13.5.5.1  Company footprint               365

13.5.5.2  Region footprint   366

13.5.5.3  Offering footprint 367

13.5.5.4  Expression system footprint                369

13.5.5.5  Application footprint            371

13.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        372

13.6.1      PROGRESSIVE COMPANIES         372

13.6.2      RESPONSIVE COMPANIES            372

13.6.3      DYNAMIC COMPANIES  372

13.6.4      STARTING BLOCKS         372

13.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 374

13.6.5.1  Detailed list of key startups/SMES   374

13.6.5.2  Competitive benchmarking of startups/SMEs 375

13.7         COMPANY VALUATION AND FINANCIAL METRICS                 376

13.7.1      COMPANY VALUATION 376

13.7.2      FINANCIAL METRICS      376

13.8         BRAND/PRODUCT COMPARISON             377

13.9         COMPETITIVE SCENARIO             378

13.9.1      PRODUCT/SERVICE LAUNCHES                 378

13.9.2      DEALS  379

13.9.3      EXPANSIONS     380

14            COMPANY PROFILES      382

14.1         KEY PLAYERS     382

14.1.1      THERMO FISHER SCIENTIFIC INC.            382

14.1.1.1  Business overview 382

14.1.1.2  Products and services offered             383

14.1.1.3  Recent developments           388

14.1.1.3.1                Product/Service launches   388

14.1.1.3.2                Deals      389

14.1.1.3.3                Expansions             389

14.1.1.4  MnM view              390

14.1.1.4.1                Key strengths        390

14.1.1.4.2                Strategic choices   390

14.1.1.4.3                Weaknesses and competitive threats 391

14.1.2      MERCK KGAA    392

14.1.2.1  Business overview 392

14.1.2.2  Products and services offered             393

14.1.2.3  Recent developments           395

14.1.2.3.1                Deals      395

14.1.2.3.2                Expansions             396

14.1.2.4  MnM view              398

14.1.2.4.1                Key strengths        398

14.1.2.4.2                Strategic choices   398

14.1.2.4.3                Weaknesses and competitive threats 398

14.1.3      DANAHER CORPORATION           399

14.1.3.1  Business overview 399

14.1.3.2  Products and services offered             400

14.1.3.3  Recent developments           402

14.1.3.3.1                Product/Service launches   402

14.1.3.3.2                Deals      403

14.1.3.3.3                Expansions             403

14.1.3.4  MnM view              404

14.1.3.4.1                Key strengths        404

14.1.3.4.2                Strategic choices   404

14.1.3.4.3                Weaknesses and competitive threats 404

14.1.4      AGILENT TECHNOLOGIES, INC.                405

14.1.4.1  Business overview 405

14.1.4.2  Products and services offered             406

14.1.4.3  MnM view              409

14.1.4.3.1                Key strengths        409

14.1.4.3.2                Strategic choices   409

14.1.4.3.3                Weaknesses and competitive threats 409

14.1.5      SARTORIUS AG 410

14.1.5.1  Business overview 410

14.1.5.2  Products and services offered             411

14.1.5.3  Recent developments           412

14.1.5.3.1                Deals      412

14.1.5.3.2                Expansions             413

14.1.5.4  MnM view              414

14.1.5.4.1                Key strength          414

14.1.5.4.2                Strategic choices   414

14.1.5.4.3                Weaknesses and competitive threats 414

14.1.6      GENSCRIPT        415

14.1.6.1  Business overview 415

14.1.6.2  Products and services offered             416

14.1.6.3  Recent developments           417

14.1.6.3.1                Product/Service launches   417

14.1.6.4  MnM view              418

14.1.6.4.1                Key strengths        418

14.1.6.4.2                Strategic choices   418

14.1.6.4.3                Weaknesses and competitive threats 418

14.1.7      TAKARA BIO INC.             419

14.1.7.1  Business overview 419

14.1.7.2  Products and services offered             421

14.1.8      BIO-RAD LABORATORIES, INC.  423

14.1.8.1  Business overview 423

14.1.8.2  Products and services offered             424

14.1.9      QIAGEN                426

14.1.9.1  Business overview 426

14.1.9.2  Products and services offered             428

14.1.10   CHARLES RIVER LABORATORIES               429

14.1.10.1                 Business overview 429

14.1.10.2                 Products and services offered             431

14.1.11   CORNING INCORPORATED         432

14.1.11.1                 Business overview 432

14.1.11.2                 Products and services offered             433

14.1.12   LONZA 435

14.1.12.1                 Business overview 435

14.1.12.2                 Products and services offered             436

14.1.12.3                 Recent developments           438

14.1.12.3.1             Product/Service launches   438

14.1.12.3.2             Deals      438

14.1.13   FUJIFILM IRVINE SCIENTIFIC, INC.           439

14.1.13.1                 Business overview 439

14.1.13.2                 Products and services offered             440

14.1.13.3                 Recent developments           442

14.1.13.3.1             Product/Service launches   442

14.1.13.3.2             Deals      442

14.1.13.3.3             Expansions             443

14.1.14   SYNGENE INTERNATIONAL LIMITED     444

14.1.14.1                 Business overview 444

14.1.14.2                 Products and services offered             445

14.1.14.3                 Recent developments           445

14.1.14.3.1             Product/Service launches   445

14.1.15   LGC LIMITED    446

14.1.15.1                 Business overview 446

14.1.15.2                 Products and services offered             447

14.1.16   EUROFINS SCIENTIFIC  448

14.1.16.1                 Business overview 448

14.1.16.2                 Products and services offered             449

14.1.17   AJINOMOTO CO., INC.   450

14.1.17.1                 Business overview 450

14.1.17.2                 Products and services offered             451

14.2         OTHER PLAYERS              452

14.2.1      PROMEGA CORPORATION           452

14.2.2      SINO BIOLOGICAL, INC.                453

14.2.3      RAYBIOTECH, INC.          454

14.2.4      BIONEER CORPORATION             455

14.2.5      ORIGENE TECHNOLOGIES, INC.                456

14.2.6      NEW ENGLAND BIOLABS              457

14.2.7      ACCURUS BIOSCIENCES               458

14.2.8      ARAGEN LIFE SCIENCES LTD.     459

14.2.9      OXFORD EXPRESSION TECHNOLOGIES LTD       460

14.2.10   PROTEOGENIX INC.        461

14.2.11   ABEOMICS          462

15            APPENDIX           463

15.1         DISCUSSION GUIDE        463

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                467

15.3         CUSTOMIZATION OPTIONS        469

15.4         RELATED REPORTS         469

15.5         AUTHOR DETAILS           470

LIST OF TABLES

TABLE 1                PROTEIN EXPRESSION MARKET: INCLUSIONS AND EXCLUSIONS           46

TABLE 2                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              57

TABLE 3                PROTEIN EXPRESSION MARKET: RISK ASSESSMENT     60

TABLE 4                PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS           71

TABLE 5                BIOLOGICS AND CELL LINES FOR PRODUCTION                 72

TABLE 6                PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING         74

TABLE 7                AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS,

2021–2023 (USD)                83

TABLE 8                AVERAGE SELLING PRICE OF SYSTEM TYPES, BY KEY PLAYER, 2023 (USD)               84

TABLE 9                AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS,

BY KEY PLAYER, 2021–2023 (USD)              85

TABLE 10              AVERAGE SELLING PRICE OF PROTEIN EXPRESSION CONSUMABLE PRODUCTS,

BY REGION, 2023 (USD) 87

TABLE 11              AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS,

BY REGION, 2021–2023 (USD)      88

TABLE 12              PROTEIN EXPRESSION MARKET: ROLE OF COMPANIES IN ECOSYSTEM       94

TABLE 13              PATENTS FILED, BY DOCUMENT TYPE, 2014–2024        103

TABLE 14              PROTEIN EXPRESSION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024             105

TABLE 15              IMPORT DATA FOR MASS SPECTROMETERS HS CODE (902781),

2022–2023, (USD THOUSAND)     106

TABLE 16              IMPORT DATA FOR MASS SPECTROMETERS HS CODE (902781),

2022–2023, (UNIT)             107

TABLE 17              EXPORT DATA FOR MASS SPECTROMETERS HS CODE (902781),

2022–2023, (USD THOUSAND)     108

TABLE 18              EXPORT DATA FOR MASS SPECTROMETERS HS CODE (902781),

2022–2023, (UNIT)             109

TABLE 19              PROTEIN EXPRESSION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025                 109

TABLE 20              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 111

TABLE 21              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           112

TABLE 22              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 113

TABLE 23              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 114

TABLE 24              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  114

TABLE 25              PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS           115

TABLE 26              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING                117

TABLE 27              BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS, BY END USER            119

TABLE 28              BUYING CRITERIA FOR PROTEIN EXPRESSION SERVICES, BY END USER                120

TABLE 29              PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)            125

TABLE 30              PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            126

TABLE 31              NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)                 126

TABLE 32              EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            126

TABLE 33              ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            127

TABLE 34              LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            127

TABLE 35              MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)            127

TABLE 36              PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                128

TABLE 37              PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION)                 129

TABLE 38              NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            129

TABLE 39              EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS,

BY COUNTRY, 2022–2029 (USD MILLION)               129

TABLE 40              ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            130

TABLE 41              LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)            130

TABLE 42              MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION)       130

TABLE 43              PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS,

BY REGION, 2022–2029 (USD MILLION)   131

TABLE 44              NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)            132

TABLE 45              EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION) 132

TABLE 46              ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)            132

TABLE 47              LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)            133

TABLE 48              MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY REGION, 2022–2029 (USD MILLION)            133

TABLE 49              PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY REGION, 2022–2029 (USD MILLION)                 134

TABLE 50              NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            134

TABLE 51              EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS,

BY COUNTRY, 2022–2029 (USD MILLION)               134

TABLE 52              ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            135

TABLE 53              LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            135

TABLE 54              MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY REGION, 2022–2029 (USD MILLION)            135

TABLE 55              PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE,

BY REGION, 2022–2029 (USD MILLION)   136

TABLE 56              NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS AND SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     137

TABLE 57              EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)       137

TABLE 58              ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     137

TABLE 59              LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)     138

TABLE 60              MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022–2029 (USD MILLION)          138

TABLE 61              PROTEIN EXPRESSION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            139

TABLE 62              NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            139

TABLE 63              EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            139

TABLE 64              ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            140

TABLE 65              LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            140

TABLE 66              MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)            140

TABLE 67              PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)                142

TABLE 68              PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   143

TABLE 69              NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     143

TABLE 70              EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       144

TABLE 71              ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            144

TABLE 72              LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     145

TABLE 73              MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            145

TABLE 74              PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         145

TABLE 75              PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            146

TABLE 76              NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     147

TABLE 77              EUROPE: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       147

TABLE 78              ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            147

TABLE 79              LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     148

TABLE 80              MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            148

TABLE 81              PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 149

TABLE 82              NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     149

TABLE 83              EUROPE: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 84              ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 85              LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     151

TABLE 86              MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            151

TABLE 87              PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   152

TABLE 88              NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     152

TABLE 89              EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 152

TABLE 90              ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       153

TABLE 91              LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     153

TABLE 92              MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 153

TABLE 93              PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   154

TABLE 94              NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     154

TABLE 95              EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 155

TABLE 96              ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       155

TABLE 97              LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     156

TABLE 98              MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)       156

TABLE 99              PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         156

TABLE 100            PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            157

TABLE 101            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       157

TABLE 102            EUROPE: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               158

TABLE 103            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 158

TABLE 104            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       159

TABLE 105            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            159

TABLE 106            PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 160

TABLE 107            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     160

TABLE 108            EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            160

TABLE 109            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     161

TABLE 110            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     161

TABLE 111            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            161

TABLE 112            PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   162

TABLE 113            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     162

TABLE 114            EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 163

TABLE 115            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       163

TABLE 116            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     164

TABLE 117            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 164

TABLE 118            PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         164

TABLE 119            PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION,

2022–2029 (USD MILLION)            165

TABLE 120            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 166

TABLE 121            EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 122            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 123            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               167

TABLE 124            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   167

TABLE 125            PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 168

TABLE 126            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     168

TABLE 127            EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            168

TABLE 128            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            169

TABLE 129            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     169

TABLE 130            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            169

TABLE 131            PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)                 170

TABLE 132            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       171

TABLE 133            EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 134            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 171

TABLE 135            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       172

TABLE 136            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            172

TABLE 137            PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                 172

TABLE 138            PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION,

2022–2029 (USD MILLION)            173

TABLE 139            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 140            EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)                 174

TABLE 141            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)                 174

TABLE 142            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               175

TABLE 143            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2022–2029 (USD MILLION)                 175

TABLE 144            PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            176

TABLE 145            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       176

TABLE 146            EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS,

BY COUNTRY, 2022–2029 (USD MILLION)               176

TABLE 147            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            177

TABLE 148            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       177

TABLE 149            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            177

TABLE 150            PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   178

TABLE 151            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     178

TABLE 152            EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 179

TABLE 153            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       179

TABLE 154            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     180

TABLE 155            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)       180

TABLE 156            PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   181

TABLE 157            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            181

TABLE 158            EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 181

TABLE 159            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 182

TABLE 160            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)            182

TABLE 161            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 182

TABLE 162            PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)   183

TABLE 163            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     183

TABLE 164            EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 184

TABLE 165            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)       184

TABLE 166            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     185

TABLE 167            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)       185

TABLE 168            PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 187

TABLE 169            PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2022–2029 (USD MILLION)                 188

TABLE 170            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022–2029 (USD MILLION)       188

TABLE 171            EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION,

BY COUNTRY, 2022–2029 (USD MILLION)               188

TABLE 172            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION,

BY COUNTRY, 2022–2029 (USD MILLION)               189

TABLE 173            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022–2029 (USD MILLION)       189

TABLE 174            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2022–2029 (USD MILLION)            189

TABLE 175            PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND

POST-TRANSLATIONAL MODIFICATION, BY REGION, 2022–2029 (USD MILLION) 190

TABLE 176            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,

2022–2029 (USD MILLION)            190

TABLE 177            EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,

2022–2029 (USD MILLION)            191

TABLE 178            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,

2022–2029 (USD MILLION)            191

TABLE 179            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,

2022–2029 (USD MILLION)            192

TABLE 180            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION,

2022–2029 (USD MILLION)            192

TABLE 181            PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2022–2029 (USD MILLION)          193

TABLE 182            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY,

2022–2029 (USD MILLION)            193

TABLE 183            EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)     193

TABLE 184            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)               194

TABLE 185            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)                 194

TABLE 186            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2022–2029 (USD MILLION)   194

TABLE 187            PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              196

TABLE 188            PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            197

TABLE 189            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            197

TABLE 190            EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               198

TABLE 191            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 198

TABLE 192            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            199

TABLE 193            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            199

TABLE 194            PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)  200

TABLE 195            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       201

TABLE 196            EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               201

TABLE 197            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               201

TABLE 198            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       202

TABLE 199            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   202

TABLE 200            LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS 203

TABLE 201            PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            204

TABLE 202            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       204

TABLE 203            EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               204

TABLE 204            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               205

TABLE 205            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       205

TABLE 206            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   205

TABLE 207            PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            207

TABLE 208            PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)          208

TABLE 209            NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)            208

TABLE 210            EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   209

TABLE 211            ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            209

TABLE 212            LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)            210

TABLE 213            MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)            210

TABLE 214            PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)       211

TABLE 215            NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               211

TABLE 216            EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     212

TABLE 217            ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               212

TABLE 218            LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               213

TABLE 219            MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)   213

TABLE 220            PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)          214

TABLE 221            NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 215

TABLE 222            EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 215

TABLE 223            ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 216

TABLE 224            LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 216

TABLE 225            MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION) 216

TABLE 226            PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)                 217

TABLE 227            NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER

END USERS, BY COUNTRY, 2022–2029 (USD MILLION)     217

TABLE 228            EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               218

TABLE 229            ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            218

TABLE 230            LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER

END USERS, BY COUNTRY, 2022–2029 (USD MILLION)     219

TABLE 231            MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER

END USERS, BY REGION, 2022–2029 (USD MILLION)          219

TABLE 232            PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            221

TABLE 233            PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)          222

TABLE 234            NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)            222

TABLE 235            EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   223

TABLE 236            ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   223

TABLE 237            LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            224

TABLE 238            MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)        224

TABLE 239            PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 225

TABLE 240            NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               225

TABLE 241            EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     225

TABLE 242            ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     226

TABLE 243            LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               226

TABLE 244            MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            226

TABLE 245            PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)                 227

TABLE 246            NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER

END USERS, BY COUNTRY, 2022–2029 (USD MILLION)     227

TABLE 247            EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               228

TABLE 248            ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            228

TABLE 249            LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER

END USERS, BY COUNTRY, 2022–2029 (USD MILLION)     229

TABLE 250            MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)            229

TABLE 251            PROTEIN EXPRESSION MARKET, BY REGION, 2022–2029 (USD MILLION)            231

TABLE 252            NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            233

TABLE 253            NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            233

TABLE 254            NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            233

TABLE 255            NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            234

TABLE 256            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                234

TABLE 257            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            234

TABLE 258            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            235

TABLE 259            NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 235

TABLE 260            NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            235

TABLE 261            NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 236

TABLE 262            NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 236

TABLE 263            NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            236

TABLE 264            NORTH AMERICA: KEY MACROECONOMIC INDICATORS      237

TABLE 265            US: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     238

TABLE 266            US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            238

TABLE 267            US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 239

TABLE 268            US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)                239

TABLE 269            US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 239

TABLE 270            US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         240

TABLE 271            US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         240

TABLE 272            US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                 240

TABLE 273            US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              241

TABLE 274            US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            241

TABLE 275            US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            241

TABLE 276            CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            243

TABLE 277            CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            243

TABLE 278            CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            243

TABLE 279            CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            244

TABLE 280            CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 244

TABLE 281            CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            244

TABLE 282            CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            245

TABLE 283            CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         245

TABLE 284            CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            245

TABLE 285            CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            246

TABLE 286            CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            246

TABLE 287            EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            247

TABLE 288            EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            247

TABLE 289            EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            247

TABLE 290            EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            248

TABLE 291            EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 248

TABLE 292            EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            248

TABLE 293            EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            249

TABLE 294            EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         249

TABLE 295            EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            249

TABLE 296            EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            250

TABLE 297            EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            250

TABLE 298            EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            250

TABLE 299            EUROPE: KEY MACROECONOMIC INDICATORS                 251

TABLE 300            GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            252

TABLE 301            GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            253

TABLE 302            GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            253

TABLE 303            GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            253

TABLE 304            GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 254

TABLE 305            GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            254

TABLE 306            GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            254

TABLE 307            GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         255

TABLE 308            GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            255

TABLE 309            GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            255

TABLE 310            GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            256

TABLE 311            UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     257

TABLE 312          UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            257

TABLE 313            UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION) 257

TABLE 314            UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)                258

TABLE 315            UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 258

TABLE 316            UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         258

TABLE 317            UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         259

TABLE 318            UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                 259

TABLE 319            UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              259

TABLE 320          UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            260

TABLE 321            UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            260

TABLE 322            FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            261

TABLE 323            FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            261

TABLE 324            FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            262

TABLE 325            FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            262

TABLE 326            FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 262

TABLE 327            FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            263

TABLE 328            FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            263

TABLE 329            FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         263

TABLE 330            FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            264

TABLE 331            FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            264

TABLE 332            FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            264

TABLE 333            ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     265

TABLE 334            ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            266

TABLE 335            ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            266

TABLE 336            ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            266

TABLE 337            ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 267

TABLE 338            ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            267

TABLE 339            ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            267

TABLE 340            ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         268

TABLE 341            ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            268

TABLE 342            ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            268

TABLE 343            ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            269

TABLE 344            SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     270

TABLE 345            SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            270

TABLE 346            SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            270

TABLE 347            SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            271

TABLE 348            SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 271

TABLE 349            SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            271

TABLE 350            SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            272

TABLE 351            SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         272

TABLE 352            SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            272

TABLE 353            SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            273

TABLE 354            SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            273

TABLE 355            NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            274

TABLE 356            NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            274

TABLE 357            NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            274

TABLE 358            NETHERLANDS: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            275

TABLE 359            NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                275

TABLE 360            NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            275

TABLE 361            NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            276

TABLE 362            NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 276

TABLE 363            NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            276

TABLE 364            NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            277

TABLE 365            NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            277

TABLE 366            REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            278

TABLE 367            REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            278

TABLE 368            REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            278

TABLE 369            REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            279

TABLE 370            REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                279

TABLE 371            REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            279

TABLE 372            REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            280

TABLE 373            REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 280

TABLE 374            REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            280

TABLE 375            REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 281

TABLE 376            REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 281

TABLE 377            ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            283

TABLE 378            ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            283

TABLE 379            ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            283

TABLE 380            ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            284

TABLE 381            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)       284

TABLE 382            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 284

TABLE 383            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 285

TABLE 384            ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            285

TABLE 385            ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            285

TABLE 386            ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            286

TABLE 387            ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            286

TABLE 388            ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            286

TABLE 389            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      288

TABLE 390            CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     289

TABLE 391            CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            289

TABLE 392            CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            289

TABLE 393            CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            290

TABLE 394            CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 290

TABLE 395            CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            290

TABLE 396            CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            291

TABLE 397            CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         291

TABLE 398            CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            291

TABLE 399            CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            292

TABLE 400            CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            292

TABLE 401            JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     293

TABLE 402            JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            293

TABLE 403            JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            294

TABLE 404            JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            294

TABLE 405            JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 294

TABLE 406            JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            295

TABLE 407            JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            295

TABLE 408            JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         295

TABLE 409            JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            296

TABLE 410            JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            296

TABLE 411            JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            296

TABLE 412            INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)     297

TABLE 413            INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            298

TABLE 414            INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            298

TABLE 415            INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            298

TABLE 416            INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 299

TABLE 417            INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            299

TABLE 418            INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            299

TABLE 419            INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         300

TABLE 420            INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            300

TABLE 421            INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            300

TABLE 422            INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            301

TABLE 423            AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            302

TABLE 424            AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            302

TABLE 425            AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            302

TABLE 426            AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            303

TABLE 427            AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)       303

TABLE 428            AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 303

TABLE 429            AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 304

TABLE 430            AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         304

TABLE 431            AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            304

TABLE 432            AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            305

TABLE 433            AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            305

TABLE 434          SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            306

TABLE 435            SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            306

TABLE 436          SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            306

TABLE 437          SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            307

TABLE 438            SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)       307

TABLE 439            SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 307

TABLE 440            SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 308

TABLE 441            SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            308

TABLE 442          SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            308

TABLE 443            SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            309

TABLE 444            SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            309

TABLE 445            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            310

TABLE 446            REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                 310

TABLE 447            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            311

TABLE 448            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            311

TABLE 449            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                312

TABLE 450            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            312

TABLE 451            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            312

TABLE 452            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 313

TABLE 453            REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            313

TABLE 454            REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 313

TABLE 455            REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 314

TABLE 456            LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            315

TABLE 457            LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            315

TABLE 458            LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            315

TABLE 459            LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            316

TABLE 460            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                316

TABLE 461            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            316

TABLE 462            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            317

TABLE 463            LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 317

TABLE 464            LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            317

TABLE 465            LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            318

TABLE 466            LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            318

TABLE 467            LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          318

TABLE 468            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      319

TABLE 469            BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            320

TABLE 470            BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            320

TABLE 471            BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            321

TABLE 472            BRAZIL: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            321

TABLE 473            BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 321

TABLE 474            BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            322

TABLE 475            BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            322

TABLE 476            BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         322

TABLE 477            BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            323

TABLE 478            BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            323

TABLE 479            BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            323

TABLE 480            MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            324

TABLE 481            MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            325

TABLE 482            MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            325

TABLE 483            MEXICO: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            325

TABLE 484            MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 326

TABLE 485            MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            326

TABLE 486            MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            326

TABLE 487            MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         327

TABLE 488            MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            327

TABLE 489            MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            327

TABLE 490            MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            328

TABLE 491            ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            328

TABLE 492            ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            329

TABLE 493            ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            329

TABLE 494            ARGENTINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            330

TABLE 495            ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)       330

TABLE 496            ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 330

TABLE 497            ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 331

TABLE 498            ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            331

TABLE 499            ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            331

TABLE 500            ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            332

TABLE 501            ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            332

TABLE 502            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            333

TABLE 503            REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            333

TABLE 504            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            333

TABLE 505            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)            334

TABLE 506            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)    334

TABLE 507            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)    334

TABLE 508            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)         335

TABLE 509            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                335

TABLE 510            REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            335

TABLE 511            REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               336

TABLE 512            REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               336

TABLE 513            MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            337

TABLE 514            MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            337

TABLE 515            MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            337

TABLE 516            MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            338

TABLE 517            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)       338

TABLE 518            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 338

TABLE 519            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 339

TABLE 520            MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            339

TABLE 521            MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            339

TABLE 522            MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            340

TABLE 523            MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            340

TABLE 524            MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION,

2022–2029 (USD MILLION)            340

TABLE 525            MIDDLE EAST: KEY MACROECONOMIC INDICATORS      341

TABLE 526            GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            342

TABLE 527            GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            343

TABLE 528            GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            343

TABLE 529            GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            344

TABLE 530            GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                344

TABLE 531            GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            344

TABLE 532            GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            345

TABLE 533            GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 345

TABLE 534            GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            345

TABLE 535            GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 346

TABLE 536            GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            346

TABLE 537            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            347

TABLE 538            REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                 347

TABLE 539            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            347

TABLE 540            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            348

TABLE 541            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)                348

TABLE 542            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            348

TABLE 543            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            349

TABLE 544            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 349

TABLE 545            REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            349

TABLE 546            REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)                 350

TABLE 547            REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 350

TABLE 548            AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING,

2022–2029 (USD MILLION)            351

TABLE 549            AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            351

TABLE 550            AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)            351

TABLE 551            AFRICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE,

2022–2029 (USD MILLION)            352

TABLE 552            AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION) 352

TABLE 553            AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            352

TABLE 554            AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)            353

TABLE 555            AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,

BY TYPE, 2022–2029 (USD MILLION)         353

TABLE 556            AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            353

TABLE 557            AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            354

TABLE 558            AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            354

TABLE 559            AFRICA: KEY MACROECONOMIC INDICATORS                 355

TABLE 560            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, JANUARY 2021–SEPTEMBER 2024              357

TABLE 561            PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION 361

TABLE 562            PROTEIN EXPRESSION MARKET: REGION FOOTPRINT       366

TABLE 563            PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT       367

TABLE 564            PROTEIN EXPRESSION MARKET: EXPRESSION SYSTEM FOOTPRINT      369

TABLE 565            PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT       371

TABLE 566            PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUP/SMES      374

TABLE 567            PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          375

TABLE 568            PROTEIN EXPRESSION MARKET: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                378

TABLE 569            PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024                379

TABLE 570            PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024                380

TABLE 571            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          382

TABLE 572            THERMO FISHER SCIENTIFIC INC.: PRODUCTS AND SERVICES OFFERED              383

TABLE 573            THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                388

TABLE 574            THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                389

TABLE 575          THERMO FISHER SCIENTIFIC INC.: EXPANSIONS,

JANUARY 2021–SEPTEMBER 2024                389

TABLE 576            MERCK KGAA: COMPANY OVERVIEW     392

TABLE 577            MERCK KGAA: PRODUCTS AND SERVICES OFFERED             393

TABLE 578            MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024              395

TABLE 579            MERCK KGAA: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              396

TABLE 580            DANAHER CORPORATION: COMPANY OVERVIEW          399

TABLE 581            DANAHER CORPORATION: PRODUCTS AND SERVICES OFFERED        400

TABLE 582            DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                402

TABLE 583            DANAHER CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2024   403

TABLE 584            DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024                403

TABLE 585            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          405

TABLE 586            AGILENT TECHNOLOGIES, INC.: PRODUCTS AND SERVICES OFFERED              406

TABLE 587            SARTORIUS AG: COMPANY OVERVIEW  410

TABLE 588            SARTORIUS AG: PRODUCTS AND SERVICES OFFERED             411

TABLE 589            SARTORIUS AG: DEALS, JANUARY 2021–SEPTEMBER 2024              412

TABLE 590            SARTORIUS AG: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              413

TABLE 591            GENSCRIPT: COMPANY OVERVIEW         415

TABLE 592            GENSCRIPT: PRODUCTS AND SERVICES OFFERED             416

TABLE 593            GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024                417

TABLE 594            TAKARA BIO INC.: COMPANY OVERVIEW                 419

TABLE 595            TAKARA BIO INC.: PRODUCTS AND SERVICES OFFERED             421

TABLE 596            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          423

TABLE 597            BIO-RAD LABORATORIES, INC.: PRODUCTS AND SERVICES OFFERED              424

TABLE 598            QIAGEN: COMPANY OVERVIEW 426

TABLE 599            QIAGEN: PRODUCTS AND SERVICES OFFERED                 428

TABLE 600            CHARLES RIVER LABORATORIES: COMPANY OVERVIEW          429

TABLE 601            CHARLES RIVER LABORATORIES: PRODUCTS AND SERVICES OFFERED              431

TABLE 602            CORNING INCORPORATED: COMPANY OVERVIEW          432

TABLE 603            CORNING INCORPORATED: PRODUCTS AND SERVICES OFFERED        433

TABLE 604            LONZA: COMPANY OVERVIEW  435

TABLE 605            LONZA: PRODUCTS AND SERVICES OFFERED                 436

TABLE 606            LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024                438

TABLE 607            LONZA: DEALS, JANUARY 2021–SEPTEMBER 2024                 438

TABLE 608            FUJIFILM IRVINE SCIENTIFIC, INC.: COMPANY OVERVIEW          439

TABLE 609            FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCTS AND SERVICES OFFERED              440

TABLE 610            FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024        442

TABLE 611            FUJIFILM IRVINE SCIENTIFIC, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                442

TABLE 612          FUJIFILM IRVINE SCIENTIFIC, INC.: EXPANSIONS,

JANUARY 2021–SEPTEMBER 2024                443

TABLE 613            SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW   444

TABLE 614            SYNGENE INTERNATIONAL LIMITED: PRODUCTS AND SERVICES OFFERED     445

TABLE 615            SYNGENE INTERNATIONAL LIMITED: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                445

TABLE 616            LGC LIMITED: COMPANY OVERVIEW     446

TABLE 617            LGC LIMITED: PRODUCTS AND SERVICES OFFERED             447

TABLE 618            EUROFINS SCIENTIFIC: COMPANY OVERVIEW                 448

TABLE 619            EUROFINS SCIENTIFIC: PRODUCTS AND SERVICES OFFERED        449

TABLE 620            AJINOMOTO CO., INC.: COMPANY OVERVIEW                 450

TABLE 621            AJINOMOTO CO., INC.: PRODUCTS AND SERVICES OFFERED        451

TABLE 622            PROMEGA CORPORATION: COMPANY OVERVIEW          452

TABLE 623            SINO BIOLOGICAL, INC.: COMPANY OVERVIEW                 453

TABLE 624            RAYBIOTECH, INC.: COMPANY OVERVIEW                 454

TABLE 625            BIONEER CORPORATION: COMPANY OVERVIEW          455

TABLE 626            ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW          456

TABLE 627            NEW ENGLAND BIOLABS: COMPANY OVERVIEW                 457

TABLE 628            ACCURUS BIOSCIENCES: COMPANY OVERVIEW                 458

TABLE 629            ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW          459

TABLE 630            OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW   460

TABLE 631            PROTEOGENIX INC.: COMPANY OVERVIEW                 461

TABLE 632            ABEOMICS: COMPANY OVERVIEW           462

LIST OF FIGURES

FIGURE 1              PROTEIN EXPRESSION MARKET SEGMENTATION AND REGIONAL SCOPE              45

FIGURE 2              PROTEIN EXPRESSION MARKET: RESEARCH DESIGN                49

FIGURE 3              PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARY INTERVIEWS            51

FIGURE 4              PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023      52

FIGURE 5              GLOBAL MARKET SIZE ESTIMATION FOR OFFERINGS: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023           53

FIGURE 6              ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.:

REVENUE SHARE ANALYSIS, 2023               53

FIGURE 7              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             54

FIGURE 8              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                55

FIGURE 9              PROTEIN EXPRESSION MARKET: CAGR PROJECTIONS   56

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 58

FIGURE 11            PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2024 VS. 2029 (USD MILLION)         61

FIGURE 12            PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)       62

FIGURE 13            PROTEIN EXPRESSION MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)      62

FIGURE 14            PROTEIN EXPRESSION PRODUCTS MARKET, BY PRODUCT TYPE,

2024 VS. 2029 (USD MILLION)      63

FIGURE 15            PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)      63

FIGURE 16            PROTEIN EXPRESSION SERVICES MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)      64

FIGURE 17            GEOGRAPHICAL SNAPSHOT OF PROTEIN EXPRESSION MARKET    65

FIGURE 18            INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET 66

FIGURE 19            US AND PRODUCTS SEGMENT DOMINATED NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2023                 67

FIGURE 20            MAMMALIAN CELL EXPRESSION SYSTEM TO LEAD MARKET DURING

FORECAST PERIOD         67

FIGURE 21            PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023        68

FIGURE 22            PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT REGISTERED HIGHEST MARKET SHARE IN 2023  68

FIGURE 23            CHINA TO HAVE HIGHEST CAGR DURING FORECAST PERIOD         69

FIGURE 24            PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          70

FIGURE 25            APPROVED DRUGS AND BIOLOGICS IN US, 2014–2024        73

FIGURE 26            APPROVED DRUG TYPE IN US, 2023         73

FIGURE 27            APPROVED PERSONALIZED MEDICINES IN US, 2014–2023              76

FIGURE 28            REVENUE SHIFT AND NEW POCKETS FOR PLAYERS IN PROTEIN EXPRESSION MARKET       82

FIGURE 29            AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS,

2021–2023              83

FIGURE 30            AVERAGE SELLING PRICE OF SYSTEM TYPES, BY KEY PLAYER, 2023             84

FIGURE 31            AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS,

BY KEY PLAYER, 2021–2023            86

FIGURE 32            AVERAGE SELLING PRICE OF PROTEIN EXPRESSION CONSUMABLE PRODUCTS,

BY REGION, 2023               87

FIGURE 33            AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS,

BY REGION, 2021–2023    88

FIGURE 34            PROTEIN EXPRESSION MARKET: SUPPLY CHAIN ANALYSIS            90

FIGURE 35            PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS               91

FIGURE 36            PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS               92

FIGURE 37            PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS            93

FIGURE 38            TYPES OF EXPRESSION SYSTEMS              98

FIGURE 39            METHODS OF PROTEIN EXTRACTION   100

FIGURE 40            PROTEIN EXPRESSION MARKET: PATENT ANALYSIS,

JANUARY 2014–SEPTEMBER 2024                104

FIGURE 41            PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS           115

FIGURE 42            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING                117

FIGURE 43            KEY BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS, BY END USER 118

FIGURE 44            KEY BUYING CRITERIA FOR PROTEIN EXPRESSION SERVICES, BY END USER    120

FIGURE 45            NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT       232

FIGURE 46            ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT          282

FIGURE 47            REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION) 359

FIGURE 48            MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023        360

FIGURE 49            PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       364

FIGURE 50            PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT       365

FIGURE 51            PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 373

FIGURE 52            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024            376

FIGURE 53            EV/EBITDA OF KEY VENDORS, 2024         376

FIGURE 54            PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON             377

FIGURE 55            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)             383

FIGURE 56            MERCK KGAA: COMPANY SNAPSHOT (2023)                 393

FIGURE 57            DANAHER CORPORATION: COMPANY SNAPSHOT (2023)             400

FIGURE 58            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)             406

FIGURE 59            SARTORIUS AG: COMPANY SNAPSHOT (2023)                 411

FIGURE 60            GENSCRIPT: COMPANY SNAPSHOT (2023)                 416

FIGURE 61            TAKARA BIO INC.: COMPANY SNAPSHOT (2023)                 420

FIGURE 62            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)             424

FIGURE 63            QIAGEN: COMPANY SNAPSHOT (2023)   427

FIGURE 64            CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)             430

FIGURE 65            CORNING INCORPORATED: COMPANY SNAPSHOT (2023)             433

FIGURE 66            LONZA: COMPANY SNAPSHOT (2023)     436

FIGURE 67            FUJIFILM IRVINE SCIENTIFIC, INC.: COMPANY SNAPSHOT (2023)             440

FIGURE 68            SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023)      444

FIGURE 69            LGC LIMITED: COMPANY SNAPSHOT (2023)                 446

FIGURE 70            EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)    449

FIGURE 71            AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2023)    451

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 原子間力顕微鏡市場 – 2030年までの世界予測 2025-07-15
• 北米のヘルスケアIT市場 – 2030年までの世界予測 2025-07-15
• オーラルケア市場 – 2030年までの世界予測 2025-07-15
• テクニカルテキスタイル市場 – 2030年までの世界予測 2025-07-15
• 燃料電池発電機市場 – 2030年までの世界予測 2025-07-15

MarketsandMarkets  出版レポート一覧